Prostate Cancer Disparities in the VA Health System - Megan McNamara
January 21, 2019
Dan George and Megan McNamara discuss the details of a project focused on prostate cancer disparities in the VA health system, leading to her 2018 PCF Young Investigator Award. This work builds upon the Abi Race trial and includes the PANTHER cohort focused on genomic data specific to the African American population. Part two of the project is an extension of the Moonshot Initiative where the VA health system is studying next generation sequencing via the Precision Oncology Program, (POP) in patients with advanced prostate cancer.
Biographies:
Megan McNamara, MD, Medical Oncologist, Assistant Professor of Medicine Member of the Duke Cancer Institute
Daniel George, MD
Related Content:
Abi Race: A Prospective, Multicenter Study of Black and White Patients with mCRPC Treated with Abiraterone Acetate and Prednisone
Prospective Study of Apalutamide and Abiraterone Acetate iN ChemoTHerapy-Naïve mEn With mCRPC Stratified by Race
Watch: Clinical Implications of the Abi Race Study: Interview with Dan George
Abi Race: A Prospective, Multicenter Study of Black and White Patients with mCRPC Treated with Abiraterone Acetate and Prednisone
Prospective Study of Apalutamide and Abiraterone Acetate iN ChemoTHerapy-Naïve mEn With mCRPC Stratified by Race
Watch: Clinical Implications of the Abi Race Study: Interview with Dan George